【医脉通-指南】2015+APA实践指南:成人精神病学评估
发布时间:2024-11-21
发布时间:2024-11-21
APAOFFICIALACTIONS
TheAmericanPsychiatricAssociationPracticeGuidelinesforthePsychiatricEvaluationofAdults
JoelJ.Silverman,M.D.,MarcGalanter,M.D.,MagaJackson-Triche,M.D.,M.S.H.S.,DouglasG.Jacobs,M.D.,JamesW.LomaxII,M.D.,MichelleB.Riba,M.D.,LowellD.Tong,M.D.,KatherineE.Watkins,M.D.,M.S.H.S.,LauraJ.Fochtmann,M.D.,M.B.I.,RichardS.Rhoads,M.D.,JoelYager,M.D.
AtitsDecembermeeting,TheAPABoardofTrusteesap-provedtheAPAWorkGrouponPsychiatricEvaluation’sPracticeGuidelinesforthePsychiatricEvaluationofAdults.[Thefullguidelineisavailableathttp:///doi/book/10.1176/appi.books.9780890426760].BACKGROUNDANDDEVELOPMENTPROCESSThesePracticeGuidelinesforthePsychiatricEvaluationofAdultsmarkatransitionintheAmericanPsychiatricAsso-ciation’sPracticeGuidelines.Sincethepublicationofthe2011InstituteofMedicinereportClinicalPracticeGuidelinesWeCanTrust,therehasbeenanincreasingfocusonusingclearlyde ned,transparentprocessesforratingthequalityofevi-denceandthestrengthoftheoverallbodyofevidenceinsystematicreviewsofthescienti cliterature.Theseguide-linesweredevelopedusingaprocessintendedtobeconsistentwiththerecommendationsoftheInstituteofMedicine(2011),thePrinciplesfortheDevelopmentofSpecialtySocietyClinicalGuidelinesoftheCouncilofMedicalSpecialtySocieties(2012),andtherequirementsoftheAgencyforHealthcareResearchandQuality(AHRQ)forinclusionofaguidelineintheNationalGuidelineClearinghouse.Parametersusedfortheguidelines’systematicreviewareincludedwiththefulltextoftheguidelines;thedevelopmentprocessisfullydescribedinadocumentavailableontheAPAwebsite:http:///File%20Library/Practice/APA-Guideline-Development-Process–updated-2011-.pdf.Tosupplementtheexpertiseofmembersoftheguidelineworkgroup,weuseda“snowball”surveymethodologytoidentifyexpertsonpsychiatricevaluationandsolicittheirinputonaspectsofthepsychiatricevaluationthattheysawaslikelytoimprovespeci cpatientoutcomes(Yager2014).Resultsofthisexpertsurveyareincludedwiththefulltextofthepracticeguideline.
Ratingthestrengthofresearchevidenceandrecommendations
ThenewguidelinerecommendationsareratedusingGRADE(GradingofRecommendationsAssessment,DevelopmentandEvaluation),anapproachadoptedbymultipleprofessionalorganizationsaroundtheworldtodeveloppracticeguidelinerecommendations(Guyattetal.,2013).WiththeGRADE
798
http://
approach,thestrengthofaguidelinestatementre ectsthelevelofcon dencethatpotentialbene tsofaninterventionoutweighthepotentialharms(Andrewsetal.,2013).Thislevelofcon denceisinformedbyavailableevidence,whichincludesevidencefromclinicaltrialsaswellasexpertopinionandpatientvaluesandpreferences.Evidenceforthebene tofaparticularinterventionwithinaspeci cclinicalcontextisidenti edthroughsystematicreviewandisthenbalancedagainsttheevidenceforharms.Inthisregard,harmsarebroadlyde nedandmightincludedirectandindirectcostsoftheintervention(includingopportunitycosts)aswellaspo-tentialforadverseeffectsfromtheintervention.Wheneverpossible,wehavefollowedtheadmonitiontocurrentguidelinedevelopmentgroupstoavoidusingwordssuchas“might”or“consider”indraftingtheserecommendationsastheycanbedif cultforclinicianstointerpret(Shiffmanetal.,2005).
Asdescribedunder“GuidelineDevelopmentProcess,”each nalratingisaconsensusjudgmentoftheauthorsoftheguidelinesandisendorsedbytheAPABoardofTrustees.A“recommendation”(denotedbythenumeral1aftertheguidelinestatement)indicatescon dencethatthebene tsoftheinterventionclearlyoutweighharms.A“suggestion”(denotedbythenumeral2aftertheguidelinestatement)indicatesuncertainty(i.e.,thebalanceofbene tsandharmsisdif culttojudge,oreitherthebene tsortheharmsareunclear).Eachguidelinestatementalsohasanassociatedratingforthe“strengthofsupportingresearchevidence.”Threeratingsareused:high,moderate,orlow(denotedbythelettersA,BandC,respectively)andre ectthelevelofcon dencethattheevidencere ectsatrueeffectbasedonconsistencyof ndingsacrossstudies,directnessoftheeffectonaspeci chealthoutcome,andprecisionoftheestimateofeffectandriskofbiasinavailablestudies(AHRQ2014;Balshemetal.2011;Guyattetal.2006).
Itiswellrecognizedthatthereareguidelinetopicsandclinicalcircumstancesforwhichhighqualityevidencefromclinicaltrialsisnotpossibleorisunethicaltoobtain(CouncilofMedicalSpecialtySocieties,2012).Forexample,itwouldnotbeethicaltorandomlyassignonlyhalfofpatientswithdepressiontobeaskedaboutsuicidalideas.Manyquestionsneedtobeaskedaspartoftheassessment,andinquiringaboutaparticularsymptomorelementofthehistorycannot
AmJPsychiatry172:8,August2015
beseparatedoutforstudyasadiscreteintervention.Itwouldalsobeimpossibletoseparatechangesinoutcomeduetoas-sessmentfromchangesinoutcomesduetoensuingtreatment.Researchonpsychiatricassessmentisalsocomplicatedbymultipleconfoundingfactorssuchastheinteractionbetweentheclinicianandthepatientorthepatient’suniquecircum-stancesandexperiences.Fortheseandotherreasons,thevastmajorityoftopicscoveredintheseguidelinesonpsychiatricevaluationhavereliedonformsofevidencesuchasconsensusopinionsofexperiencedcliniciansorindirect ndingsfromobservationalstudiesratherthanbeingbasedonresearchfromrandomizedtrials.TheGRADEworkinggroupandguidelinesdevelopedbyotherprofessionalorganizationshavenotedthatastrongrecommendationmaybeappro-priateevenintheabsenceofresearchevidencewhensensiblealternativesdonotexist(Andrewsetal.2013;Britoetal.2013;Djulbegovicetal.2009;Hazlehurstetal.2013).
Goalsandscopeofguidelinesforthepsychiatricevaluationofadults
Despitethedif cultiesinobtainingquantitativeevidencefromrandomizedtrialsforpracticeguidelinessuchaspsy-chiatricevaluation,guidancetoclinicianscanstillbebene- cialinenhancingcaretopatients.Thus,inthecontextofaninitialpsychiatricevaluation,amajorgoaloftheseguidelinesistoimprovetheidenti cationofpsychiatricsignsandsymptoms,psychiatricdisorders(includingsubstanceusedisorders),othermedicalconditions(thatcouldaffecttheaccuracyofapsychiatricdiagnosis),andpatientswhoareatincreasedriskforsuicidaloraggressivebehaviors.Additionalgoalsrelatetoidentifyingfactorsthatcouldin uencethetherapeuticalliance,enhanceclinicaldecisionmaking,enablesafeandappropriatetreatmentplanning,andpromotebettertreatmentoutcomes.Finally,thepsychiatricevaluationisthestartofadialogwithpatientsaboutmanyfactors,includingdiagnosisandtreatmentoptions.Furthergoalsoftheseguide-linesaretoimprovecollaborativedecisionmakingbetweenpatientsandcliniciansabouttreatment-relateddecisionsaswellastoincreasecoordinationofpsychiatrictreatmentwithotherclinicianswhomaybeinvolvedinthepatient’scare.Timerequiredtocompleteapsychiatricevaluation
Itisessentialtonotethattheseguidelinesarenotintendedtobecomprehensiveinscope.Manycriticalaspectsofthepsychiatricevaluationarenotaddressedbytheseguidelines.Forexample,itisassumedthatinitialpsychiatricorothermedicalassessmentswillneedtoidentifythereasonthatthepatientispresentingforevaluation.Itissimilarlyimportanttounderstandthepatient’sbackground,relationships,lifecircumstances,strengthsandvulnerabilities.
Furthermore,dependingonthecontext,recommendedareasofinquirymayneedtobepostponeduntillatervisits,andrecommendedquestionswillnotalwaysbeindicatedforaspeci cpatient.The ndingsoftheexpertsurveyreiteratethatexpertsvaryintheextenttowhichparticularelementsoftheinitialpsychiatricevaluationareassessed.Thisalso
AmJPsychiatry172:8,August2015
APAOFFICIALACTIONS
highlightstheimportanceofclinicaljudgmentintailoringthepsychiatricevaluationtotheuniquecircumstancesofthepatientandindeterminingwhichquestionsaremostim-portanttoaskaspartofaninitialassessment.
Properuseofguidelines
TheAmericanPsychiatricAssociationPracticeGuidelinesarenotintendedtoserveorbeconstruedasa“standardofmedicalcare.”Judgmentsconcerningclinicalcaredependontheclinicalcircumstancesanddataavailableforanindividualpatientandaresubjecttochangeasscienti cknowledgeandtechnologyad-vanceandpracticepatternsevolve.Theseguidelinestatementsweredeterminedonthebasisoftherelativebalanceofpotentialbene tsandharmsofaspeci cassessment,interventionorotherapproachtocare.Assuch,itisnotpossibletodrawconclusionsabouttheeffectsofomittingaparticularrecommendation,eitheringeneralorforaspeci cpatient.Furthermore,adherencetotheseguidelineswillnotensureasuccessfuloutcomeforeveryindividual,norshouldtheseguidelinesbeinterpretedasin-cludingallpropermethodsofevaluationandcareorexcludingotheracceptablemethodsofevaluationandcareaimedatthesameresults.Theultimaterecommendationregardingapar-ticularassessment,clinicalprocedure,ortreatmentplanmustbemadebythepsychiatristinlightofthepsychiatricevaluation,otherclinicaldata,andthediagnosticandtreatmentoptionsavailable.Suchrecommendationsshouldbemadeincollabo-rationwiththepatientandfamily,wheneverpossible,andin-corporatethepatient’spersonalandsocioculturalpreferencesandvaluesinordertoenhancethetherapeuticalliance,ad-herencetotreatment,andtreatmentoutcomes.
Organizationofthepracticeguidelinesforthepsychiatricevaluationofadults
Aspartofaligningthepracticeguidelines’developmentprocesswithnationalstandards,wehavetransitionedtoanewguidelineformat.EachsetofPracticeGuidelineswillconsistofmultiplediscretetopicsofrelevancetoanoverallsubjectarea.InthePracticeGuidelinesforthePsychiatricEvaluationofAdults,thesetopicsconsistofReviewofPsy-chiatricSymptoms,TraumaHistory,andPsychiatricTreat-mentHistory;SubstanceUseAssessment;AssessmentofSuicideRisk;AssessmentofRiskforAggressiveBehaviors;AssessmentofCulturalFactors;AssessmentofMedicalHealth;QuantitativeAssessment;InvolvementofthePatientinTreatmentDecisionMaking;andDocumentationofthePsychiatricEvaluation.Foreachtopic,guidelinestatementswillbefollowedbyadiscussionoftherationale,potentialbene tsandharms,andapproachestoimplementingtheguidelinestatements.ThisportionofthePracticeGuidelinesisexpectedhavethegreatestutilityforclinicians.AsecondsectionofthePracticeGuidelinesprovidesadetailedreviewoftheevidenceforguidelinestatementsinaccordwithnationalguidelinedevelopmentstandards.Thisreviewofresearchevidenceanddatafromtheexpertsurveyisfollowedbyadiscussionofqualitymeasurementconsiderations,in-cludingtheirappropriatenessforeachtopic.
http://
799
APAOFFICIALACTIONS
TABLE1.PracticeGuidelinesforthePsychiatricEvaluationofAdultsGuidelineTitle
IReviewofPsychiatricSymptoms,TraumaHistory,andPsychiatricTreatmentHistoryIISubstanceUseAssessmentIIIAssessmentofSuicideRisk
IVAssessmentofRiskforAggressiveBehaviorsVAssessmentofCulturalFactorsVIAssessmentofMedicalHealthVIIQuantitativeAssessment
VIIIInvolvementofthePatientinTreatmentDecision-Making
IX
DocumentationofthePsychiatricEvaluation
GUIDELINESANDSTATEMENTS
ThefollowingrepresentsasummaryoftherecommendationsandsuggestionscompiledfromallPracticeGuidelinesforthePsychiatricEvaluationofAdults(Table1),withsomestatementsbeingapartofmorethanoneoftheseguidelines.Inthecontextoftheseguidelinestatements,itisimportanttonotethatassessmentisnotlimitedtodirectexamina-tionofthepatient.Rather,itisde nedas“theprocessofobtaininginformationaboutapatientthroughanyofavarietyofmethods,includingface-to-faceinterview,reviewofmedicalrecords,physicalexamination(bythepsychiatrist,anotherphysician,oramedicallytrainedclinician),diagnostictesting,orhistory-takingfromcollateralsources.”Theevaluationmayalsorequireseveralmeetings,withthepatient,family,orothers,beforeitcanbecompleted.Theamountoftimespentdependsonthecomplexityoftheproblem,theclinicalset-ting,andthepatient’sabilityandwillingnesstocooperatewiththeassessment.
Thissummaryisorganizedaccordingtocommonhead-ingsofanevaluationnote.Asnotedabove,theguidelinesarenotintendedtobecomprehensive,andmanyaspectsofthepsychiatricevaluationarenotaddressedbytheserecom-mendationsandsuggestions.Thestrengthofsupportingre-searchevidencefortheserecommendationsandsuggestionsisgivenratingC(low)becauseofthedif cultiesinstudyingpsychiatricassessmentapproachesincontrolledstudiesasdescribedinthe“BackgroundandDevelopmentProcess.”Thespeci cguideline(s)inwhichtherecommendationorsuggestionisfoundisdenotedbyitsRomannumeralfromTable1.
Historyofpresentillness
Inadditiontoreasonsthatthepatientispresentingforeval-uation,APArecommends(1C)thattheinitialpsychiatricevaluationofapatientinclude:
Psychiatricreviewofsystems(I),includinganxietysymptomsandpanicattacks(III)
Assessmentofpastorcurrentsleepabnormalities,in-cludingsleepapnea(VI)
Assessmentofimpulsivity(III,IV)
800
http://
Psychiatrichistory
APArecommends(1C)thattheinitialpsychiatricevaluationofapatientincludeassessmentofthefollowing:
PastPriorandpsychoticcurrentorpsychiatricaggressivediagnosesideas,including(I,III)
thoughtsofphysicalorsexualaggressionorhomicide(IV)
Prioraggressivebehaviors(e.g.,homicide,domesticorwork-placeviolence,otherphysicallyorsexuallyaggressivethreatsoracts)(IV)
Priorsuicidalideas,suicideplans,andsuicideattempts,includingattemptsthatwereabortedorinterruptedaswellasthedetailsofeachattempt(e.g.,context,method,damage,potentiallethality,intent)(III)
Priorintentionalself-injuryinwhichtherewasnosuicidalintent(III)
APArecommends(1C)thattheinitialpsychiatricevalu-ationofapatientincludereviewofthefollowingaspectsofthepatient’spsychiatrictreatmenthistory:
Historyofpsychiatrichospitalizationandemergencyde-partmentvisitsforpsychiatricissues(I,III,IV)
Pastpsychiatrictreatments(type,duration,and,whereapplicable,doses)(I)
Responsetotopastpastpsychiatricandcurrenttreatmentspharmacological(I)
Adherenceandnon-pharmacologicalpsychiatrictreatments(I)
Substanceusehistory
APArecommends(1C)thattheinitialpsychiatricevaluationofapatientincludeassessmentofthefollowing:
Thepatient’suseoftobacco,alcohol,andothersubstances(e.g.,marijuana,cocaine,heroin,hallucinogens)andanymisuseofprescribedorover-the-countermedicationsorsupplements(II)
Currentorrecentsubstanceusedisorderorchangeinuseofalcoholorothersubstances(III,IV)
Medicalhistory(VI).APArecommends(1C)thattheinitialpsychiatricevaluationofapatientincludeassessmentofthefollowing:
Allergiesordrugsensitivities
Allmedicationsthepatientiscurrentlyorrecentlytakingandthesideeffectsofthesemedications(i.e.,bothpre-scribedandnonprescribedmedications,herbalandnu-tritionalsupplements,andvitamins)
Whetherornotthepatienthasanongoingrelationshipwithaprimarycarehealthprofessional
Pastorcurrentmedicalillnessesandrelatedhospitalizations Relevantpastorcurrenttreatments,includingsurgeries,otherprocedures,orcomplementaryandalternativemed-icaltreatments
Pastorcurrentneurologicalorneurocognitivedisordersorsymptoms(IV)
Physicaltrauma,includingheadinjuries Sexualandreproductivehistory
AmJPsychiatry172:8,August2015
APAsuggests(2C)thattheinitialpsychiatricevaluationofapatientalsoincludeassessmentofthefollowing:
Cardiopulmonarystatus
PastPastororcurrentcurrentinfectiousendocrinologicaldisease,disease
includingsexuallytrans-mitteddiseases,HIV,tuberculosis,hepatitisC,andlocallyendemicinfectiousdiseasessuchasLymedisease
Pastorcurrentsymptomsorconditionsassociatedwithsigni cantpainanddiscomfort
Reviewofsystems(VI).APArecommends(1C)thattheinitialpsychiatricevaluationofapatientincludeapsychiatricreviewofsystems(ifnotalreadyincludedwithhistoryofpresentillness)
Inadditiontoapsychiatricreviewofsystems,APAsug-gests(2C)thattheinitialpsychiatricevaluationofapatientincludeareviewofthefollowingsystems:
ConstitutionalEyes
symptoms(e.g.,fever,weightloss) Ears, CardiovascularNose,Mouth,Throat Respiratory Gastrointestinal Genitourinary Musculoskeletal
Integumentary Neurological(skinand/orbreast) Endocrine
Hematological/Lymphatic
Allergic/Immunological
Familyhistory
APArecommends(1C)thattheinitialpsychiatricevaluationofapatientwhoreportscurrentsuicidalideasincludeas-sessmentofhistoryofsuicidalbehaviorsinbiologicalrela-tives(forpatientswithcurrentsuicidalideas)(III)
Whenitisdeterminedduringaninitialpsychiatricevaluationthatthepatienthasaggressiveideas,APArec-ommends(1C)assessmentofhistoryofviolentbehaviorsinbiologicalrelatives(forpatientswithcurrentaggressiveideas)(IV)
Personalandsocialhistory
APArecommends(1C)thattheinitialpsychiatricevaluationofapatientincludeassessmentofthefollowing:
Presenceofpsychosocialstressors,(e.g. nancial,housing,legal,school/occupationalorinterpersonal/relationshipproblems;lackofsocialsupport;painful,dis guring,orterminalmedicalillness)(III,IV)
Reviewofthepatient’straumahistory(I,III)
Exposuretoviolenceoraggressivebehavior,includingcombatexposureorchildhoodabuse(IV)
Legalordisciplinaryconsequencesofpastaggressivebehaviors(IV)
AmJPsychiatry172:8,August2015
APAOFFICIALACTIONS
CulturalfactorsrelatedtothepatientPatient’sneedforaninterpreter(V)
’ssocialenvironment(V) APAsuggests(2C)thattheinitialpsychiatricevaluationofapatientincludeassessmentofthepatient’sPersonal/culturalbeliefsandculturalexplanationsofpsychiatricillness(V)
Examination,includingmentalstatusexamination
APAsuggests(2C)thattheinitialpsychiatricevaluationofapatientalsoincludeassessmentofthefollowing:
Height,weight,Skin,signsincluding(VI)
andbodymassindex(BMI)(VI) Vital anystigmataoftrauma,self-injury,ordruguse(VI)
APArecommends(1C)thattheinitialpsychiatricevalu-ationofapatientincludeassessmentofthefollowing: General Coordinationappearanceandnutritionalstatus(VI) Involuntary Sightmovementsandgait(VI)
orabnormalitiesofmotortone(VI) Speech,and
Mood,levelincludinghearing(VI)
ofanxiety, uencythoughtandarticulationcontentand(VI)
process,andperceptionandcognition(I,III) HopelessnessCurrentsuicidal(III)
ideas,suicideplans,andsuicideattempts,includingactiveorpassivethoughtsofsuicideordeath(III):Ifcurrentsuicidalideasarepresent,assess:
°Patient’sintendedcourseofactionifcurrentsymptomsworsen
°°AccessPatient’tospossiblesuicidemotivationsmethodsincludingforsuicide rearms
(e.g.attentionorreactionfromothers,revenge,shame,humiliation,de-lusionalguilt,commandhallucinations)
°Reasonsforliving(e.g.senseofresponsibilitytochildrenorothers,religiousbeliefs)
°Qualityandstrengthorpsychoticofthetherapeuticideas,includingalliance
Currentaggressivethoughtsofphysicalorsexualaggressionorhomicide(III,IV):Ifcurrentaggressiveideasarepresent,assess:
°Speci cindividualsorgroupstowardwhomhomicidaloraggressiveideasorbehaviorshavebeendirectedinthepastoratpresent
°°Impulsivity,Accessto rearms
includingangermanagementissuesImpressionandplan
APArecommends(1C)thattheclinicianwhoconductstheinitialpsychiatricevaluationdocument:
Anestimateofthepatient’ssuiciderisk,includingfactorsin uencingrisk(III)
Therationalefortreatmentselection,includingdiscus-sionofthespeci cfactorsthatin uencedthetreatmentchoice(IX)
http://
801
APAOFFICIALACTIONS
APArecommends(1C)thattheinitialpsychiatricevalu-ationofapatientwhoisseeninclude:
Askingthepatientaboutthetreatment-relatedpatientofthefollowing:preferencesthe(VIII) Anexplanationtodif-ferentialdiagnosis,risksofuntreatedillness,treatmentoptions,andbene tsandrisksoftreatment(VIII)
Collaborationbetweentheclinicianandthepatientaboutdecisionspertinenttotreatment(VIII)
APAsuggests(2C)thattheinitialpsychiatricevaluationofapatientinclude:
Quantitativemeasuresofsymptoms,leveloffunctioning,andqualityoflife(VII)
Documentationofanestimatedriskofaggressivebehavior(includinghomicide),includingfactorsin uencingrisk(IV) Documentationoftherationaleforclinicaltests(IX)
AUTHORANDARTICLEINFORMATION
FromtheAPAWorkgrouponPsychiatricEvaluation(JoelJ.Silverman,Chair).AddresscorrespondencetoKristinKroeger(kkroeger@http://).APAwishestoacknowledgethecontributionsoftheformerAPAstaff;RobertKunkle,M.A.,RobertPlovnick,M.D.,SaraReid,M.A.,Seung-HeeHong,andWilliamE.Narrow,M.D.,M.P.H.APAandtheWorkGrouponPsychiatricEvaluationespeciallythankLauraJ.Fochtmann,M.D.,M.B.I,andRobertKunkle,M.A.fortheiroutstandingworkandeffortonde-velopingtheseguidelines.APAalsothankstheAPASteeringCommitteeonPracticeGuidelinesandliaisonsfromtheAPAAssemblyfortheirinputandassistance.
AmJPsychiatry2015;172:798–802;doi:10.1176/appi.ajp.2015.1720501
REFERENCES
AgencyforHealthcareResearchandQuality:MethodsGuideforEffectivenessandComparativeEffectivenessReviews.AHRQPublication
http://No.10(14)-EHC063-EF.Rockville,MD:AgencyforHealthcareResearchandQuality.Jan2014.Chaptersavailableat:www.effectivehealthcare.ahrq.gov.
AndrewsJC,SchünemannHJ,OxmanAD,etal:GRADEguidelines:15.Goingfromevidencetorecommendation-determinantsofarec-ommendation’sdirectionandstrength.JClinEpidemiol2013;66:726–735
BalshemH,HelfandM,SchünemannHJ,etal:GRADEguidelines:3.Ratingthequalityofevidence.JClinEpidemiol2011;64:401–406BritoJP,DomecqJP,MuradMH,etal:TheEndocrineSocietyguidelines:whenthecon dencecartgoesbeforetheevidencehorse.JClinEndocrinolMetab2013;98:3246–3252
CouncilofMedicalSpecialtySocieties(CMSS):PrinciplesfortheDevelopmentofSpecialtySocietyClinicalGuidelines.Chicago,IL.2012
DjulbegovicB,TrikalinosTA,RobackJ,etal:Impactofqualityofevi-denceonthestrengthofrecommendations:anempiricalstudy.BMCHealthServRes2009;9:120
GuyattG,EikelboomJW,AklEA,etal:AguidetoGRADEguidelinesforthereadersofJTH.JThrombHaemost2013;11:1603–1608
GuyattG,GuttermanD,BaumannMH,etal:Gradingstrengthofrec-ommendationsandqualityofevidenceinclinicalguidelines:reportfromanamericancollegeofchestphysicianstaskforce.Chest2006;129:174–181
GuyattGH,OxmanAD,KunzR,etal:GRADEWorkingGroup:Goingfromevidencetorecommendations.BMJ2008;336:1049–1051
HazlehurstJM,ArmstrongMJ,SherlockM,etal:Acomparativequalityassessmentofevidence-basedclinicalguidelinesinendocrinology.ClinEndocrinol(Oxf)2013;78:183–190
InstituteofMedicine(IOM):ClinicalPracticeGuidelinesWeCanTrust.Washington,DC,TheNationalAcademiesPress,2011
ShiffmanRN,DixonJ,BrandtC,etal:TheGuideLineImplement-abilityAppraisal(GLIA):developmentofaninstrumenttoidentifyobstaclestoguidelineimplementation.BMCMedInformDecisMak2005;5:23
YagerJ,KunkleR,FochtmannLJ,etal:Who’syourexpert?UseofanexpertopinionsurveytoinformdevelopmentofAmericanPsy-chiatricAssociationpracticeguidelines.AcadPsychiatry2014;38:376–382
AmJPsychiatry172:8,August2015